Changjiang Securities Underwriting and Sponsorship Co., Ltd. Report on the 2025 Continuous Supervision and Follow-up of Yili Chuineng Biotechnology Co., Ltd.

✨ AI Summary

This report details Changjiang Securities' continuous supervision and follow-up work for Yili Chuineng Biotechnology in 2025. It covers information disclosure review, compliance with regulations, and supervision of fundraising and corporate governance. The company's net profit decreased by 45.13% due to lower sales and increased R&D expenses.

Summary generated by AI · Always verify with source document